Placenta-specific1 (PLAC1) is a potential target for antibody-drug conjugate-based prostate cancer immunotherapy
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Placenta-specific1 (PLAC1) is a potential target for antibody-drug conjugate-based prostate cancer immunotherapy
Authors
Keywords
-
Journal
Scientific Reports
Volume 7, Issue 1, Pages -
Publisher
Springer Nature
Online
2017-10-11
DOI
10.1038/s41598-017-13682-9
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Optimized protocol for soluble prokaryotic expression, purification and structural analysis of human placenta specific-1(PLAC1)
- (2017) Mahboobeh Nazari et al. PROTEIN EXPRESSION AND PURIFICATION
- Expanding the Reach of Antibody–Drug Conjugates
- (2016) Ravi V. J. Chari ACS Medicinal Chemistry Letters
- Sacituzumab Govitecan (IMMU-132), an Anti-Trop-2/SN-38 Antibody–Drug Conjugate: Characterization and Efficacy in Pancreatic, Gastric, and Other Cancers
- (2015) Thomas M. Cardillo et al. BIOCONJUGATE CHEMISTRY
- A Novel Anti-CD22 Anthracycline-Based Antibody-Drug Conjugate (ADC) That Overcomes Resistance to Auristatin-Based ADCs
- (2015) S.-F. Yu et al. CLINICAL CANCER RESEARCH
- High placenta-specific 1/low prostate-specific antigen expression pattern in high-grade prostate adenocarcinoma
- (2014) Roya Ghods et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Human Serum Albumin Conjugates of 7-Ethyl-10-hydroxycamptothecin (SN38) for Cancer Treatment
- (2014) Nima Sepehri et al. Biomed Research International
- Ligand-targeted particulate nanomedicines undergoing clinical evaluation: Current status
- (2013) Roy van der Meel et al. ADVANCED DRUG DELIVERY REVIEWS
- Conjugating Antibodies to Cytotoxic Agents: Getting the Best of Both Worlds?
- (2013) Anna Azvolinsky JNCI-Journal of the National Cancer Institute
- Cancer nanomedicines: So many papers and so few drugs!
- (2012) Vincent J. Venditto et al. ADVANCED DRUG DELIVERY REVIEWS
- An integrated approach to identify normal tissue expression of targets for antibody-drug conjugates: case study of TENB2
- (2012) C Andrew Boswell et al. BRITISH JOURNAL OF PHARMACOLOGY
- Humanized Anti-Trop-2 IgG-SN-38 Conjugate for Effective Treatment of Diverse Epithelial Cancers: Preclinical Studies in Human Cancer Xenograft Models and Monkeys
- (2011) T. M. Cardillo et al. CLINICAL CANCER RESEARCH
- Stem Cell Characteristics in Prostate Cancer Cell Lines
- (2009) Minja J. Pfeiffer et al. EUROPEAN UROLOGY
- Plac1 is a tumor-specific antigen capable of eliciting spontaneous antibody responses in human cancer patients
- (2008) Xue-Yuan Dong et al. INTERNATIONAL JOURNAL OF CANCER
- Antibody Conjugates of 7-Ethyl-10-hydroxycamptothecin (SN-38) for Targeted Cancer Chemotherapy
- (2008) Sung-Ju Moon et al. JOURNAL OF MEDICINAL CHEMISTRY
- Prostate cancer stem cells
- (2008) SH Lang et al. JOURNAL OF PATHOLOGY
- Targeted Cancer Therapy: Conferring Specificity to Cytotoxic Drugs
- (2007) Ravi V. J. Chari ACCOUNTS OF CHEMICAL RESEARCH
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now